We found that NR2F1 is most predominantly expressed in CAFs in the TME of primary breast cancer.
The authors present interesting findings that a tumor dormancy marker, NR2F1, is predominantly expressed in the inflammatory CAFs, and high expression of NR2F1 is associated with suppressed immune response and increased density of stromal cells. However, this reviewer has a few concerns that need to be addressed before accepting this article for publication.